Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 1,001–1,018 of 1,018
Borroni, B., Ghezzi, S., Agosti, C., Archetti, S., Fenoglio, C., Galimberti, D., Scarpini, E. A., Luca, M. D., Bresolin, N., Comi, G. P., et al. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0711 · Cited by 27
Clinical Presentation of Prodromal Frontotemporal Dementia
Hallam, B. J., Silverberg, N. D., LaMarre, A. K., Mackenzie, I. R., & Feldman, H. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507308781 · Cited by 29
Self-citationTelpoukhovskaia, M. A., Liu, K., Sayed, F. A., Etchegaray, J. I., Xie, M., Zhan, L., Li, Y., Zhou, Y., Le, D., Bahr, B. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70534-9 · Cited by 23
Progranulin in the hematopoietic compartment protects mice from atherosclerosis
Nguyen, A. D., Nguyen, T. A., Singh, R. K., Eberlé, D., Zhang, J., Abate, J. P., Robles, A., Koliwad, S., Huang, E. J., Maxfield, F. R., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.042 · Cited by 23
Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice
Vargas-Caballero, M., Denk, F., Wobst, H. J., Arch, E., Pegasiou, C.-M., Oliver, P. L., Shipton, O. A., Paulsen, O., & Wade-Martins, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00201 · Cited by 18
Josephs, K. A. (2018) · Brain · doi:10.1093/brain/awx367 · Cited by 17
Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway
Dong, T., Tejwani, L., Jung, Y., Kokubu, H., Luttik, K., Driessen, T. M., & Lim, J. (2021) · JCI Insight · doi:10.1172/jci.insight.136147 · Cited by 13
microRNA‐based predictor for diagnosis of frontotemporal dementia
Magen, I., Yacovzada, N., Warren, J. D., Heller, C., Swift, I., Bobeva, Y., Malaspina, A., Rohrer, J. D., Fratta, P., & Hornstein, E. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12916 · Cited by 12
Hermey, G., & Klein, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.361544 · Cited by 10
“Heterozygous mutations in GRN, resulting in haploinsufficiency, are the cause of frontotemporal lobar degeneration (FTLD) with TAR DNA-binding protein 43 (TDP-43) inclusions (Baker et al., 2006; Cruts et al., 2006; Gass et al., 2006).”
BackgroundThe role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis
Li, B., Chen, M., Aguzzi, A., & Zhu, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02061-7 · Cited by 7
Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Miyoshi, E., Morabito, S., & Swarup, V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105530 · Cited by 7
“Prior to GWAS, we had only identified mutations in the MAPT, GRN, C9orf72, VCP, and CHMP2B genes in familial FTD cases (Baker et al., 2006; Cruts et al., 2006; DeJesus-Hernandez et al., 2011; Hutton et al., 1998; Rohrer and Rosen, 2013; Skibinski et al., 2005; Watts et al., 2004; van der Zee et…”
MethodFuller, O. K., McLennan, E. D., Egan, C. L., Burrows, E. L., & Febbraio, M. A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114810 · Cited by 6
“To date, forty-four different MAPT mutations which lead to abnormal phosphorylation and accumulation of NFTs have been reported, accounting for 5 – 20% of familial FTD cases [8,9].”
BackgroundUnaltered prion disease in mice lacking developmental endothelial locus-1
Zhu, C., Li, Z., Li, B., Pfammatter, M., Hornemann, S., & Aguzzi, A. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.003 · Cited by 4
Graham, A. C., Bellou, E., Harwood, J. C., Yaman, U., Celikag, M., Magusali, N., Rambarack, N., Botia, J. A., Frigerio, C. S., Hardy, J., et al. (2023) · doi:10.1101/2023.03.30.23287975 · Cited by 4
Lysosomes cell autonomously regulate myeloid cell states and immune responses
Tejwani, L., Balak, C., Skuja, L. L., Tatarakis, D., Rana, A., Fitzgerald, G. A., Ha, C., Lunkes de Melo, G., Sun, E. W., Heffner, C. M., et al. (2024) · doi:10.1101/2024.11.11.623074 · Cited by 4
Lane-Donovan, C., Paredes, M., & Kao, A. W. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102854 · Cited by 3
Dickson, D. W. (2007) · Blue Books of Neurology · doi:10.1016/s1877-184x(09)70058-9 · Cited by 3
Self-citation
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.